1)Lacroix A, et al:Cushing's syndrome. Lancet 386:913-927, 2015
2)Kamilaris CDC, et al:Adrenocortical tumorigenesis;Lessons from genetics. Best Pract Res Clin Endocrinol Metab 34:101428, 2020
3)Di Dalmazi G, et al:Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes;A large cross-sectional study. Eur J Endocrinol 166:669-677, 2012
4)Fassnacht M, et al:Management of adrenal incidentalomas;European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175:G1-G34, 2016
5)Mantero F, et al:A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637-644, 2000
6)Kloos RT, et al:Incidentally discovered adrenal masses. Endocr Rev 16:460-484, 1995
7)Chiodini I:Clinical review;Diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab 96:1223-1236, 2011
8)Yanase T, et al:New diagnostic criteria of adrenal subclinical Cushing's syndrome;Opinion from the Japan Endocrine Society. Endocr J 65:383-393, 2018